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ABSTRACT Small noncoding RNAs called microRNAs (miRNAs) have emerged as post-transcriptional regulators of gene expression
related to host defenses. Here, we have used Drosophila melanogaster to explore the contribution of individual or clusters of miRNAs in
countering systemic Candida albicans infection. From a total of 72 tested, we identify 6 miRNA allelic mutant backgrounds that modulate
the survival response to infection and the ability to control pathogen number. These mutants also exhibit dysregulation of the Toll pathway
target transcripts Drosomycin (Drs) and Immune-Induced Molecule 1 (IM1). These are characteristics of defects in Toll signaling, and
consistent with this, we demonstrate dependency for one of the miRNA mutants on the NF-kΒ homolog Dif. We also quantify changes
in the miRNA expression proﬁle over time in response to three pathogen types, and identify 13 mature miRNA forms affected by pathogens
that stimulate Toll signaling. To complement this, we provide a genome-wide map of potential NF-kB sites in proximity to miRNA genes.
Finally, we demonstrate that systemic C. albicans infection contributes to a reduction in the total amount of branch-chained amino acids,
which is miRNA-regulated. Overall, our data reveal a new layer of miRNA complexity regulating the ﬂy response to systemic fungal infection.
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DROSOPHILA melanogaster has led to some signiﬁcantdiscoveries regarding the innate immune pathways in-
volved in countering a wide range of microbial infections
[reviewed in Kounatidis and Ligoxygakis (2012) and Bouchon
et al. (2014)]. Microbial detection by pattern recognition
receptors (PRRs) or sensors of “danger signals” leads to
the activation of signaling cascades that result in expression
of immune effectors and regulators.
TheToll and ImmuneDeﬁciency (IMD) signalingpathways
regulate the activation of the nuclear factor kB (NF-kB) tran-
scription factor homologs Dif/Dorsal and Relish, respectively
[reviewed in Kounatidis and Ligoxygakis (2012) and Bouchon
et al. (2014)]. Following Toll activation, a receptor–adaptor
complex, which includes the death domain-containing pro-
teins dMyD88, Pelle, and Tube, transmits the signal to the
IkB homolog Cactus. The latter is then targeted for degrada-
tion, which leaves NF-kB proteins Dif/Dorsal free to translo-
cate to the nucleus and regulate hundreds of genes (De
Gregorio et al. 2001). Among others, Toll signaling triggers
the transcription of several effector molecules including anti-
microbial peptide (AMP) genes, such as Drosomycin (Drs). Dif
enters the nucleus 20 min after infection (Ligoxygakis et al.
2002). Approximately 40 min following Dif nuclear entry, ex-
pression of the Toll pathway PRR (and target of Dif), PGRP-SA
(peptidoglycan recognition protein-SA) is 10 times that of the
basal level (De Gregorio et al. 2001, 2002). However, intracel-
lular homeostasis of the pathway remains relatively unex-
plored. This is especially pertinent in the light of recent data
that indicate that upon Toll induction, Pelle phosphorylates
Cka of the STRIPAK (Striatin-interacting phosphatase and ki-
nase) complex thus releasing Hippo signaling, which in turn
prevents cactus transcription leading to the sustained activa-
tion of the Toll pathway (Liu et al. 2016).
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MicroRNAs (miRNAs) are small noncoding RNAs, which
act as post-transcriptional regulators of gene expression.
MiRNAs are initially transcribed in the nucleus as a primary
miRNA transcript by polymerase II, which are then cleaved
into precursor miRNAs (pre-miRNAs) by the protein complex
made up by nuclear RNase III protein Drosha and the double-
stranded RNA-binding protein Pasha. The pre-miRNAs are
then exported to the cytoplasm by the protein Exportin 5,
where they are further processed byRNase III enzymeDicer-1
with the help of double-stranded RNA-binding protein Lo-
quacious to produce 22 nucleotide-long miRNA–miRNA*
duplexes. Finally, one of the miRNA strands is loaded into the
RNA-induced silencing complex (Risc), containing Argonaut-1
(Ago-1), for targeting of gene expression (Ha and Kim
2014).
Approximately 60% of all protein-coding genes have been
estimated to be under miRNA control (Grun et al. 2005). A
given miRNA can regulate several target transcripts, while an
mRNA transcript might be targeted by multiple miRNAs.
These RNAs play crucial roles in key biological processes,
such as cell proliferation, cell fate, differentiation, apoptosis,
and survival (Cayirlioglu et al. 2008; Bejarano et al. 2010;
Weng and Cohen 2012; Morante et al. 2013; Chen et al.
2014). miRNAs have also emerged as important regulators
of the host innate immune response and host–pathogen-
interactions. Garbuzov and Tatar revealed that in Drosophila,
20-HE may regulate expression of the antimicrobial peptide
Dpt via let-7 miRNA by interacting with the 39-UTR of the
target gene and repressing its translation (Garbuzov and
Tatar 2010). These authors proposed that let-7, induced at
the same time as Dpt by 20-HE, may set the limit on expres-
sion levels ofDpt by negatively regulating it to set a threshold
for the AMP following immune induction, thus avoiding over-
stimulation of the innate immune system. Two other studies
in Drosophila have indicated that miRNA-8 plays a role in
maintaining the innate immune response (Choi and Hyun
2012; Lee and Hyun 2014). In these studies, miRNA-8 has
been shown to regulate the levels of basal expression of AMPs
such as Drs and Dpt. They revealed that, in the absence of
infection, miRNA-8 targets the Toll receptor and Dorsal. By
targeting these proteins, miRNA-8 ensures that, when the
immune system is not stimulated, the levels of AMPs such
as Drs are kept low. The miRNA cluster 959–964 has also
been associated with immune response regulation in Drosophila
(Vodala et al. 2012). In this case, the miRNA 959–964 cluster
mutants revealed altered levels of mRNAs involved in immune
responses, including Drs.
In addition, an in silico study by Fullaondo and Lee (2012)
predicted that several other miRNAs may be involved in reg-
ulating the innate immune system, although, as yet, their
predictions have not been tested due to the lack of available
mutants. In fact, little is known about the in vivo role of
miRNAs in innate immunity across species. Recently, the con-
struction of a large collection of D. melanogaster miRNA al-
lelic mutants was reported (Chen et al. 2014). Here, we
utilize this collection to show that individual or clusters of
miRNAs alter the ability of ﬂies to cope with systemic infec-
tion, impacting on survival, the control of pathogen number,
and the production of Toll-dependent transcripts.
Materials and Methods
Fly stocks
Flies obtained from theBloomingtonDrosophilaStockCentre:
c564. Gal4 driver (#6982); UAS-myr_mRFP (#7118); Dif1
loss-of-function allele (#36559); UAS-miR-277Sponge (#61408);
the control backgroundsw1118 (#5905), y1w1 (#1495), and the
isogenicwild-type strain (#25174; originally from theDrosophila
Genetics Reference Panel); and the collection of miRNA allelic
mutants (Chen et al. 2014). Fly lines carrying UAS (upstream
activating sequence)-RNA interference (RNAi) constructs were
obtained from the Vienna Drosophila RNAi Centre: PGAP5RNAi
(#47953); Exp5RNAi (#31706 and #31707); Dcr-1RNAi
(#24667); LoqsRNAi (#22453); and Myd88RNAi (#25402).
Yolk. Gal4 was kindly provided by Bruno Lemaitre. We also
used the previously described strains UAS-Ago-1 andUAS-Dcr-1
(Dietzl et al. 2007), and miR-124D6 (Sun et al. 2012). All ﬂies
were raised on maize malt molasses food in a light-dark (12-hr
cycle) incubator at 25 and 60% humidity. Flies were shifted to
30 and 60% humidity following infection for microarray,
branch-chained amino acid (BCAA) quantiﬁcation experiments,
and those involvingmiRNA allelic mutants. Flies were shifted to




Candida albicans strain SC5314 was streaked intermittently
from a280 stock onto Sabouraud Agar (SGA), grown at 30
for 36 hr, and stored at 4 for up to a week. The inoculant was
prepared from a single colony grown in 10 ml Sabouraud
Broth (SGB) for 18–21 hr at 30 and shaken at 200 rpm; this
was washed and resuspended in PBS to an OD600 of 0.95–
1.05 (readings taken with a NanoDrop 1000 spectrophotom-
eter; Thermo Fisher Scientiﬁc) and further diluted fourfold
in PBS for injection into ﬂies. Staphylococcus aureus strain
NCTC-8325 was streaked intermittently from a 280 stock
onto Tryptic Soy Agar, grown at 30 for 36 hr, and stored at 4
for up to a week. The inoculant was prepared from a single
colony grown in 10 ml Tryptic Soy Broth for 16–18 hr at 30
and shaken at 200 rpm; this was washed and resuspended in
PBS to an OD600 of 0.36 and further diluted 1000-fold in PBS
for injection into ﬂies. Escherichia coli strain 1106 was cul-
tured in amanner similar to S. aureus, but Luria-Bertani agar/
broth was used and the OD600 0.36 suspension was not fur-
ther diluted prior to injection.
Screening the collection of miRNA allelic mutants
Two to three-day-old femaleﬂieswere anesthetizedwithCO2,
and 13.8 nl of C. albicans inoculant (800 yeast cells) in-
jected into the dorsolateral region of the thorax using a Nano-
ject II Injector (Drummond Scientiﬁc) coupled to a ﬁne glass
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needle. Flies were kept at 30 following infection; a compro-
mise between conditions for C. albicans growth and ﬂy re-
sistance to temperature. Survival was monitored every 24 hr
over a 3-day period; lethality during the ﬁrst 6 hr was attrib-
uted to effects associated with the injection procedure and
was subtracted from the survival data. The miRNA allelic
mutants were infected as several groups with each group in-
cluding a background control, either w or yw. The survival
proﬁle of a particular mutant background was compared to
that of the group control via the Log-rank test, and P-values
adjusted for multiple comparisons using the Holm–Sˇidák
method. For miRNA mutants whose survival proﬁle statisti-
cally separated from their group control, a second round of
C. albicans infection was performed; for further comparison,
additional backgrounds were included that did not separate
from their group control. In addition, most second-round
miRNA mutant backgrounds were injected with 13.8 nl PBS
and selected with 13.8 nl E. coli. All conﬁrmed second-round
miRNA mutants were tested for a third time, conﬁrming the
differences in estimated survival probabilities found previously.
Toestimate changes inpathogennumberduring the course
of infection six, infected female ﬂies were homogenized in
SGB at speciﬁc time points (0, 24, and 48 hr); the homoge-
nates were serially diluted, plated on SGA, and incubated for
36 hr at 30 to enable suitable colony growth for counting.
To determine changes in the levels of Drs and Immune-
induced Molecule 1 (IM1) transcripts during the course of in-
fection, total RNAwas extracted from six femaleﬂies at speciﬁc
time points (0, 24, and 48 hr) using the Total RNA Puriﬁcation
Plus Kit (Cat. No. 48400; Norgen Biotek); this uses a column
that efﬁciently removes genomic DNA. Purity and concentra-
tion of the RNA samples were checked using a NanoDrop
1000 spectrophotometer (Thermo Fisher Scientiﬁc), and
500 ng of RNA reverse transcribed in a total volume of 20 ml
using the SensiFAST cDNA Synthesis Kit (Cat. No. BIO-65054;
Bioline, London, UK). Template cDNA—2 ml diluted 10-fold—
was ampliﬁed using the SensiFast SYBR No-ROX Kit (Cat. No.
BIO-98005; Bioline) and primer pairs against Drs, IM1, or
TATA-Binding Protein (dTBP) at a concentration of 400 nM
per primer; cycling was performed in a Rotor-Gene Q real-time
PCR machine (QIAGEN, Valencia, CA). The amount of tran-
script was expressed as 2(2DCT), where DCT is the average
threshold cycle (CT) value for the gene of interest (Drs/IM1)
subtracted from the average CT value for the internal control
(dTBP) (Schmittgen and Livak 2008). Primer pairs (59–39): Drs
(+) GTACTTGTTCGCCCTCTTCG and Drs (2) TTAGCATCC
TTCGCACCAG; IM1 (+) GAAATTCTTCTCAGTCGTC and IM1
(2) CATCAATGGCGATTGCAG; and dTBP (+) GGCAAAGAGT
GAGGACGACT and dTBP (2) GAGCCGACCATGTTTTGAAT.
Identifying potential NF-kB-binding sites in close
proximity to miRNA genes
The current version of the D. melanogaster genome (R6.12)
was used to perform the binding site analysis. The transcrip-
tion start sites (TSSs) for miRNA genes are yet to be comprehen-
sively described, but predicted or experimentally determined
TSSs generally lie within 1.5 kb of the miR-RM transcript
(Qian et al. 2011; Ryazansky et al. 2011); these are the pre-
miRNAs embedded in the primary transcripts. Therefore,
the initial base (+ 1) of the miR-RM transcript was used
as a reference for the promoter region of the corresponding
miRNA gene. A Position Weight Matrix (PWM) approach
was taken to identify potential NF-kB-binding sites within
2-kb regions ﬂanking the (+ 1) of the miR-RM transcript;
evidence from a study using a human cell line identiﬁed
functional NF-kB-binding sites upstream and downstream
of certain miRNA genes, and these sites were located up to
3 kb from the TSS (Zhou et al. 2010). The Toll and IMD
PWMs were constructed using 15 sequences identiﬁed as
overrepresented motifs upstream of Toll and IMD respon-
sive genes, respectively (Busse et al. 2007). The Rel PWM
was constructed from 31 sequences derived from a SELEX
assay using a recombinant fragment of the D. melanogaster
Rel protein, and the DIF/Rel PWM constructed from the
base frequency table derived from a SELEX assay using a
combination of recombinant DIF and Rel proteins (Senger
et al. 2004).
miRNA proﬁling
To identify changes in the miRNA proﬁle over time, a micro-
array experiment was performed. Wild-type ﬂies from the
samepopulationwere injectedwith13.8nlofeitherC.albicans,
S. aureus, E. coli, or PBS, and transferred to 30. At 0, 1, 7.5,
18, and 60 hr following injection, total RNA was puriﬁed
from 10 females using the Total RNA Puriﬁcation Plus Kit
(Cat. No. 48400; Norgen Biotek). Next, 5 mg of total RNA
(quantiﬁed using a NanoDrop 1000 spectrophotometer)
from each sample was suspended in 200 ml of precipitation
solution (3 M NaOAc, pH 5.2 and 100% ethanol) and imme-
diately frozen in liquid nitrogen; these were stored at 280
until shipment for the miRNA microarray experiment (LC
Sciences, Houston, TX). Samples were labeled with a ﬂuores-
cent dye and hybridized to a mParaﬂo Microﬂuidic Chip that
contained complementary sequences for 425 unique mature
miRNA sequences, derived from 241 D. melanogastermiRNA
genes (miRBase version 19.0). The background signal was
subtracted and data normalized prior to analysis; ANOVA
was applied to identify statistical differences. All data pro-
cessing was performed by LC Sciences and is presented as
clustered heat maps. Experiments were repeated indepen-
dently on three occasions (n = 3), except for the E. coli in-
fection, which was performed twice (n = 2).
Quantiﬁcation of branched-chain amino acids (BCAAs)
Ten ﬂies injected with PBS or C. albicans (weighing 10 mg)
were ﬂash-frozen in liquid nitrogen at time 0–24 hr following
injection. Frozen ﬂies were homogenized in 200 ml assay
buffer. Homogenates were centrifuged for 10min at 12,000 rpm,
and 10 ml of supernatant used to measure the BCAA levels
(BCAAColorimetric Assay Kit; Cat. No. K564-100; Biovision);
color intensity was quantiﬁed using a microplate reader
(CLARIOstar; BMG Labtech).
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Statistical analysis
Data were analyzed using GraphPad Prism (version 7.01) or
the R-platform. To visualize survival data, estimated survival
curves were constructed; in ﬁgures with estimated survival
probabilities, C.I.swereexcluded for clarityof image.TheLog-
rank test was used to identify statistical differences between
survival curves and P-values were adjusted for multiple com-
parisons via the Holm–Sˇidák method. Data involving a time
series (excluding the microarray data) were analyzed using
repeated-measures two-way ANOVA, and P-values adjusted
for multiple comparisons using Bonferroni correction. Single
time point data were compared via one-way or two-way
ANOVA, and P-values adjusted using the Holm–Sˇidákmethod.
Data availability
The miRNA mutant strain collection from the Cohen Lab and
the mir sponge lines are available from the Bloomington Dro-
sophila Stock Center. All P-values for Figure 6 can be found in
Supplemental Material, Table S2. The microarray data are
presented in Figure 4 for miRNA that presented statistically
signiﬁcant regulation and in Figure S3 for all others; Table S5
includes a list of P-values for the microarray analysis. Table
S4 has a list of all miRNAs that have at least one consensus
NF-kB-binding site, while Figure S4 summarizes the numbers
of miRNAs with such site(s).
Results
Disrupting miRNA biogenesis causes susceptibility to
systemic C. albicans infection and potentially inﬂuences
Toll signaling
To explore the contribution of miRNAs in controlling the
response to infection at a whole-organism level, we initially
examined the requirement formiRNAbiogenesis inprotecting
the host against infection. To perturb this process, we used
RNAi against Exp5, which transports pre-miRNAs from the
nucleus to the cytoplasm, and against Loqs and Dcr-1, which
together process the various pre-miRNAs to produce particular
miRNA duplexes that are subsequently loaded onto Ago-1. We
also examined the consequences of increasing the levels of
Ago-1, since this protein is involved inproductionof themiRNA
strand that guides translational repression/destabilization of
target mRNAs (Ha and Kim 2014). Manipulating these com-
ponents has been shown to alter the miRNA proﬁle in human
cell lines (Lee et al. 2004; Okamura et al. 2004; Hata and
Kashima 2016; Jakob et al. 2016; Kim et al. 2016).
The c564 . Gal4 driver was used to express UAS-RNAi
constructs in the major immune-responsive tissues (fat body,
hemocytes, and gut) throughout development and into adult-
hood (Hrdlicka et al. 2002; Ryu et al. 2006). Female c564 .
RNAi ﬂies were injected with either C. albicans or PBS—the
latter serving as a control for the injection procedure—and
survival monitored. None of the c564 . RNAi ﬂies exhibited
physical abnormalities, nor did they die signiﬁcantly follow-
ing injection with PBS (data not shown). Those impaired for
miRNA biogenesis (c564 . Exp5RNAi/c564 . LoqsRNAi/
c564 . Dcr-1RNAi) succumbed to systemic C. albicans infec-
tion more rapidly than a wild-type strain (see Materials and
Methods), and more rapidly than ﬂies expressing either red
ﬂuorescent protein (RFP) (c564 . RFP) or a control RNAi
construct (c564 . PGAP5RNAi) (Figure 1A). PGAP5 was
chosen as a control since it has no deﬁned role in immunity—
likewise regarding the vertebrate ortholog metallophos-
phoesterase-1—and did not exhibit resistance/tolerance or
susceptibility to C. albicans infection during a large-scale
UAS-RNAi screen (data not shown); consistent with this,
the survival of c564 . PGAP5RNAi ﬂies was inseparable from
the wild-type strain or from those expressing RFP (Figure
1A). However, ﬂies impaired formiRNA biogenesis were less
susceptible to infection than those deﬁcient in Toll signaling
(c564 . Myd88RNAi) (Figure 1A). These observations sug-
gest that having the correct complement of miRNAs within
immune tissues is necessary for ﬂies to cope with systemic
yeast infection. It may therefore be that dysfunctional miRNA
biogenesis affects the output of Toll signaling, the major re-
spondent to fungal infections. To examine this, we used
Yolk . Gal4 to overexpress Ago-1 or Dcr-1 protein, or the
Exp5RNAi construct, speciﬁcally in the fat body of female ﬂies
(Yolk . Ago-1/Yolk . Dcr-1/Yolk . Exp5RNAi); the driver is
expressed4 days after emergence of the adult and therefore
bypasses potential effects that may occur during develop-
ment (Georgel et al. 2001). Flies were again injected with
either PBS or C. albicans and a subset of each population
assessed for survival; the level of Drs transcript was mea-
sured in the surviving populations to determine an output
of Toll signaling. There were no signiﬁcant differences in
the survival dynamics for ﬂies injected with PBS (data not
shown). Consistent with that observed with c564 .
Exp5RNAi, Yolk . Exp5RNAi ﬂies succumbed to systemic
C. albicans infection more rapidly than those of the control
population (Yolk . RFP), but not as rapidly as those de-
ﬁcient for Toll signaling (Yolk . Myd88RNAi) (Figure 1B).
The survival proﬁle for Yolk . Ago-1 ﬂies was similarly
positioned, and inseparable to that of Yolk . Exp5RNAi ﬂies
(Figure 1B). Although susceptibility to infection was equiv-
alent, there were differences in their level of Drs transcript:
for Yolk.Ago-1 ﬂies this did not detectably change over the
course of infection—mirroring that observed with a Toll
pathway mutant—but it increased within Yolk . Exp5RNAi
ﬂies comparably to that observed with the Yolk . RFP con-
trol (Figure 1C). An additional feature unique to Yolk .
Exp5RNAi ﬂies was the signiﬁcant increase relative to the
control of the Drs transcript induced through PBS injection
alone (Figure 1C).
Therefore, it seems likely that correctprocessingofmiRNAs
within immune tissues is necessary to protect against systemic
C. albicans infection and, in some capacity, to control the
output of Toll signaling. To identify speciﬁc miRNAs that
contribute to either function, we used a collection of targeted
knockout miRNA mutants recently constructed in D. mela-
nogaster (Chen et al. 2014).
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Screening for miRNAs that contribute to controlling the
ﬂy’s response to systemic C. albicans infection
Todate, themiRNAmutants generated by theCohenLabhave
been assayed for changes in a variety of phenotypes but not
their response to infection (Chen et al. 2014). Therefore, we
injected the majority of available lines with C. albicans and
compared their survival proﬁles to that of a background con-
trol: in total, we evaluated 72 miRNA mutant backgrounds
covering 95 miRNAs. For miRNA mutants whose survival
proﬁle statistically separated from their control (P , 0.05),
two repeat rounds of injection were performed; included in
this were mutants whose survival proﬁles were close to but
did not separate from their control (0.1$ P. 0.05), and for
further comparison, additional lines whose survival proﬁles
were inseparable from their control (P. 0.1) (Table S1). We
identiﬁed four mutant backgrounds that were more suscep-
tible (miR-317, miR-276b, miR-277-34, and miR-310-311-
312-313) to systemic C. albicans infection, and two mutant
Figure 1 Perturbing miRNA biogenesis increases the susceptibility of ﬂies to systemic C. albicans infection and affects production of the Drs transcript.
(A) RNAi knockdown of Exp5, Dcr-1, or Loqs in the major immune tissues results in ﬂies becoming more susceptible to systemic C. albicans infection
relative to a wild-type strain, or RFP and PGAP5 controls, but they are less susceptible than immune-defective ﬂies; P , 0.001 for the wild-type strain or
either control compared to any miRNA biogenesis deﬁcient background, and when the latter are compared to the Myd88 mutant. The survival proﬁle of
the wild-type strain is inseparable to either control (P . 0.1 in both cases). (B) Likewise, when Exp5 function is reduced or Ago-1 overexpressed
speciﬁcally in the fat body, ﬂies become more sensitive to systemic C. albicans infection relative to an RFP control (P , 0.001 in both cases), but are less
sensitive than Myd88-deﬁcient ﬂies (P , 0.001 in both cases). The survival proﬁles for Yolk . Dcr-1 and control RFP ﬂies are inseparable (P . 0.2). For
clarity of image, 95% C.I.s have been omitted. (C) At the point of injection (time 0), there are generally no differences in the level of Drs transcript (PBS
injected, P. 0.6 for any comparison, except for those with Yolk.Myd88RNAi ﬂies where the transcript is slightly elevated; C. albicans injected, P. 0.05
for any comparison), implying that disrupting miRNA biogenesis per se does not alone affect its production. The amount of transcript is inseparable for
Yolk. Ago-1 and Yolk.Myd88RNAi ﬂies 24 hr following infection (P. 0.9), and does not detectably change for either from the point of injection (P.
0.9 in both cases). However, the level of Drs transcript increases during the course of infection within Yolk. Dcr-1 and Yolk. Exp5RNAi ﬂies (P, 0.001
in both cases) to that of the RFP control (P. 0.2 for both comparisons to control). Only Yolk. Exp5RNAi ﬂies exhibit a change in Drs transcript over time
from the point of PBS injection (P, 0.01). Survival proﬁles were compared using the Log-rank test (n = 35–104, combined data from three independent
infections) and P-values adjusted for multiple comparisons via the Holm–Sˇidák method. Quantiﬁcation of Drs transcript was performed independently
three times (n = 3) and is presented as mean values with 95% C.I.s; differences in relative transcript level were identiﬁed using repeated-measure two-
way ANOVA and P-values adjusted for multiple comparisons through Bonferroni correction. miRNA, microRNA; RNAi, RNA interference; RFP, red
ﬂuorescent protein; UAS, upstream activating sequence; 95% CI, 95% Conﬁdence interval.
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backgrounds that exhibited enhanced survival (miR-193 and
miR-972-973-974) (Figure 2A and Table S1). In addition,
none of the ﬂies carrying the miRNA-137 mutation suc-
cumbed to infection (see Table S1); however, due to the
low number of obtainable ﬂies at the time of injection, the
enhanced survival was not considered signiﬁcant. Finally,
none of the ﬂies for the six mutant backgrounds exhibiting
altered survival proﬁles had obvious defects to their external
morphology, as all appeared healthy, nor did they exhibit
differences in survival dynamics following PBS injection
(Table S1).
We next assessed the ability of the six miRNA mutants to
control pathogen number by quantifying their colony forming
units (CFUs) over time following inoculation with C. albicans,
and for their ability to modulate an output of Toll signaling.
These are two assays that reveal defects in classic innate
Figure 2 Assaying selected miRNA allelic mutants for characteristics indicative of defects to immune signaling. (A) Survival proﬁles for miRNA mutant
backgrounds shown to exhibit susceptibility or enhanced survival in response to systemic C. albicans infection; the estimated survival curves represent
combined data for the repeat infections (n = 29–62, see Table S1). The w and yw curves were constructed using survival data taken from the groups
within which a miRNA mutant background was originally compared: for w this is combined data from ﬁve groups (n = 153), and for yw combined data
from two groups (n = 54). Survival proﬁles for the miRNA mutants separate signiﬁcantly from their given w or yw control (P , 0.001 for any mutant
compared to control). For clarity of image, 95% C.I.s have been omitted. (B) Changes in pathogen number during the course of systemic C. albicans
infection. The initial inoculation (time 0) is equivalent for all miRNA mutants and the w and yw controls (P . 0.05 for any comparison). (C) Changes in
the level of Drs transcript following PBS injection or infection. For each miRNA mutant, conclusions regarding the dynamics of the two variables over
time and how this compares to the given control are summarized in Figure 6. CFUs and Drs quantiﬁcation were performed independently on three
occasions (n = 3) and are presented as mean values with 95% C.I.s. CFU, colony forming unit; miRNA, microRNA; 95% CI, 95% Conﬁdence interval.
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immune function, and regarding CFUs, distinguish between
mechanisms of resistance and tolerance toward infection
(Schneider and Ayres 2008). For comparison, we also evalu-
ated some of the miRNA mutants whose survival proﬁles
were inseparable from their controls. During the ﬁrst 24 hr,
pathogen number increased within the susceptible miRNA
mutants to a level greater than that observed with the w
background control (Figure 2B and Figure 6). For the miR-
317 and miR-276b susceptible mutants, pathogen number
did not detectably change during a further 24 hr of infection,
but continued to increase within the miR-277-34 mutant; at
this 48-hr time point there was more C. albicans within the
susceptible miRNA mutants than the w control (Figure 2B
and Figure 6). For miRNA backgrounds whose survival did
not differ from the w control there was, in general, no sepa-
ration of pathogen number (Figure 2B and Figure 6). The
most notable exception to this being for ﬂies carrying the
miR-33 mutation, whose CFU proﬁle was akin to that of
the susceptible mutants (Figure 2B and Figure 6). Within
themiR-972-973-974mutant, which exhibited enhanced sur-
vival, the amount of C. albicans signiﬁcantly increased over
time relative to the yw background control, for which there
was no detectable change in CFUs (Figure 2B and Figure 6).
Finally, miR-193 mutants that exhibited enhanced survival
did not show any signiﬁcant change from the initial inoculate
over the 48-hr period (Figure 2B and Figure 6).
There were signiﬁcant differences in the levels of Drs tran-
scripts between some of the miRNA mutants at the point of
injection (time 0 PBS and time 0 C. albicans, Figure 2C).
However, for mutants carrying a w allele, these were incon-
sistent between those injected with PBS and those injected
with C. albicans—the assumption being that differences
should be consistent at time 0 if there is an effect due to
mutation—and thus likely reﬂect natural variation rather
than meaningful differences resulting from inherent biologi-
cal changes. An exception to this may be themiR-304mutant,
where the level of transcript was reproducibly low across the
course of infection (Figure 2C and Figure 6); this suggests
that production of Drs mRNA may actually be compromised.
All miRNA mutants (except miR-1017) and both controls
experienced an elevation in their levels of Drs transcripts
24 hr following systemic C. albicans infection. For the suscep-
tible miR-317 and miR-277-34 mutants and enhanced sur-
vival miR-972-973-974 mutant, this was above that of the
respective w and yw control, being particularly notable for
miR-277-34; these increases resolved to the level of control
during the subsequent 24-hr infection period (Figure 2C and
Figure 6). At this 48-hr time point, miRNA mutants with
survival proﬁles similar to their control had eithermaintained
their elevated levels of Drs transcripts (miR-970 and miR-
184) or experienced a decrease to levels below that of the
w background (miR-304 and miR-33) (Figure 2C and Figure
6). The miR-276b and miR-193 mutants continued to in-
crease the level of transcript over the 48-hr infection period;
for the susceptible miR-276b mutant this was at a level com-
parable to thew control, whereas the enhanced survivalmiR-193
mutant was accumulating signiﬁcantly more (Figure 2C and
Figure 6). For ﬂies injected with PBS, only the susceptible
miR-277-34 and enhanced survival miR-972-973-974 mu-
tants exhibited a signiﬁcant increase in the levels of Drs tran-
scripts 24 hr following injection, and this was above that of
the respective control (Figure 2C and Figure 6). The miR-
972-973-974 mutant also had elevated transcript levels at
the point of injection, suggesting that basal production of
Drs is, to some degree, heightened in this mutant.
It is clear that individual or small clusters of miRNAs
contribute to control of the response to systemic C. albicans
infection through modulating the survival outcome, in gen-
eral, limiting the increase in pathogen number, and inﬂuenc-
ing the production of the Drs transcript. These are traits
associated with changes to Toll signaling. Therefore, we ex-
plored this potential connection.
miR-277 and miR-34 potentially have opposing effects
on the output of Toll signaling
Adeﬁning feature of the susceptiblemiR-277-34mutant is the
strong Drs response observed 24 hr following PBS injection.
We eliminated the increase in temperature—applied since
PBS-injected ﬂies serve as the control for infection, which
proceeds at 30—as being a causal factor, and demonstrated
that sterile pricking is sufﬁcient to invoke the response (Fig-
ure S1). This implies participation of Toll/IMD signaling,
since pricking alone induces rapid production of numerous
AMP transcripts at a low level (Lemaitre et al. 1997); pre-
sumably, in themiR-277-34mutant, this pricking effect is not
so efﬁciently downregulated. To substantiate a requirement
for Toll signaling, we repeated the PBS injection of the miR-
277-34mutantwhile simultaneously reducing the function of
Dif, themajor Toll pathway transcription factor in the context
of immunity. This suppressed the strong Drs response (Figure
3A), indicating that Toll signaling is required to produce the
pool of transcript modulated by miR-277 and/or miR-34. To
evaluate whether miR-277 alone was sufﬁcient to regulate
the level of Drs transcript in response to PBS injection and/or
infection, we used an antisense RNA to knock its function
down within the immune tissues (c564 . miR-277Sponge).
For an independent readout of Toll signaling, we also quan-
tiﬁed the relative level of IM1, a gene whose infection re-
sponse is exclusively dependent on the Toll ligand Spz (De
Gregorio et al. 2001, 2002). Although 24 hr following PBS
injection the level of Drs transcript was slightly elevated
within c564 . miR-277Sponge ﬂies compared to those of the
control, the difference was not signiﬁcant; however, there
was signiﬁcantly more transcript following infection (Figure
3B). The level of IM1 transcript was higher than that ob-
served for the control population 24 hr following either
PBS or C. albicans injection (Figure 3B); an effect equivalent
to that observed with Drs transcript in the miR-277-34 mu-
tant (Figure 2C). This suggests that miR-277 functions to
reduce signaling through the Toll pathway, and that its loss
in the miR-277-34 mutant may be the causal factor underly-
ing the response to infection. However, if a repression of Toll
miRNAs in Drosophila Immunity 169
signaling has been removed, it raises a question regarding the
susceptibility of the mutant. Therefore, we measured the
level of IM1 transcript 24 hr following PBS injection or in-
fection; in contrast to Drs, the level of transcript was com-
parable to the control following injection of PBS, and
signiﬁcantly lower in response to infection (Figure 3C). This
suggests that miR-34 functions to promote signaling through
the Toll pathway and acts downstream to the inhibitory effect
of miR-277. The elevated level of Drs transcript within the
miR-277-34mutant, if signaling through Toll is reduced, may
be a consequence of either miR-277 and/or miR34 directly
targeting the transcript. Indeed, members of the miR-310-
311-312-313 cluster and miR-964 target the 39-UTR of Drs
to reduce transcript abundance (Vodala et al. 2012; Li et al.
2017b). Therefore, we used freely available algorithms—
PITA/TargetScan/miRanda-mirSVR (Enright et al. 2003;
Kertesz et al. 2007; Ruby et al. 2007; Betel et al. 2010;
Agarwal et al. 2015)—to scan the 39-UTR of Drs and identi-
ﬁed a potential binding site for miR-277 (Table S3), suggest-
ing direct targeting of the transcript as a potential regulatory
mechanism. There were no potential sites for miR-277 in the
39-UTR or open reading frame (ORF) of IM1. The latter may
be signiﬁcant given that conserved miRNA-binding sites in
the ORF ofD.melanogastermRNAs lead to downregulation of
transcript levels (Schnall-Levin et al. 2010). There were also
no potential binding sites for miR-34 in either the Drs or IM1
transcripts (Table S3). Therefore, we speculate that loss of
miR-277 in themiR-277-34mutant results in derepression of
accumulated Drs transcript, and that this compensates for
reduced signaling through the Toll pathway due to loss of
miR-34.
From the miRNA mutants assessed for traits indicative of
defects in innate immunity (Figure 6), other than miR-277,
only miR-33 and miR-972 have potential binding sites in the
39-UTR of the Drs transcript; none of the miRNAs are pre-
dicted to target its ORF (Table S3). This is consistent with
studies demonstrating that miRNAs function in positive or
negative feedback loops that modulate signaling through
NF-kB pathways (Olarerin-George et al. 2013; Staedel and
Darfeuille 2013; Teng et al. 2013; Maudet et al. 2014; Kumar
et al. 2015; Xiong et al. 2016; Li et al. 2017b). Accordingly,
immune-induced expression (or repression) of particular
miRNAs has been shown to depend on NF-kB-binding sites
(Taganov et al. 2006; O’Hara et al. 2010; Zhou et al. 2010;
Figure 3 miR-277 and miR-34 potentially inﬂu-
ence signaling through the Toll pathway. (A)
When Dif function is also compromised, the
elevation of Drs transcript observed within the
miR-277-34 mutant 24 hr following PBS injec-
tion is abolished; P, 0.001 for any comparison
to w; miR-277-34, and P . 0.9 for all other
comparisons. (B) Knocking down the function
of miR-277 in immune tissues (c564 . miR-
277Sponge) leads to an increase in the level of
Drs transcript 24 hr following infection relative
to the control (c564 . Gal4, this is the driver
crossed to the w background, P , 0.001), and
for IM1 transcript, this is true also for PBS in-
jection (P , 0.001 for PBS injection and infec-
tion). (C) In contrast to that observed with Drs,
the level of IM1 transcript within the miR-277-
34 mutant is lower than that of the control
24 hr following infection (P , 0.001). The data
represents the mean of three independent bi-
ological repeats (n = 3/95% C.I.s) and was
compared using one-way ANOVA (A) or two-
way ANOVA (B and C); P-values were adjusted
via the Holm–Sˇidák method. 95% CI, 95% Con-
ﬁdence interval.
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Wang and Cambi 2012; Thompson et al. 2013). In an attempt
to identify miRNAs regulated by NF-kB activity, we assessed
the potential for NF-kB occupancy in proximity to miRNA
genes, and evaluated changes in the miRNA proﬁle following
systemic infection.
Distribution of potential NF-kB sites in proximity to
miRNA genes and miRNA microarray analysis following
systemic infection
A PWM approach was used to identify potential NF-kB-bind-
ing sites within 2-kb regions located either side of the ﬁrst
base (+) of the miR-RM transcripts; four PWMs were con-
structed (Table S4). Of the 256 miRNA genes in the anno-
tated D. melanogaster genome, 36% had at least three strong
NF-kB-binding sites (Figure S2), suggesting that certain
miRNAs may indeed be regulated by innate immune signal-
ing at the level of transcription.
To determine whether stimulating the Toll or IMD path-
ways altered the miRNA proﬁle over time following systemic
immune challenge, we performed a miRNA microarray ex-
periment. Wild-type ﬂies were infected with C. albicans or S.
aureus (both Toll signaling), or E. coli (IMD signaling); the
baseline was PBS injection. Samples were collected at time
points (0, 1, 7.5, 18, and 60 hr following injection) a few
hours prior to when signiﬁcant changes occurred in Toll/
IMD signaling, the assumption being that modulation of the
Figure 4 Differential production of mature miRNA forms. Wild-type ﬂies were injected with PBS or one of the given pathogens: E. coli (E. c), S. aureus
(S. a), or C. albicans (C. a). Their miRNA complement was quantiﬁed at time points T0, T1, T7.5, T18, and T60 (numbers refer to hours following
injection). Data are compared for all factors at each individual time point to identify mature miRNA forms whose production is differentially regulated;
ANOVA-selected miRNAs (P , 0.1) are presented as clustered heat maps, where negative Z-values (green) indicate downregulation relative to the data
set and positive Z-values (red) upregulation. Except with E. coli (n = 2), the infection experiments were repeated independently on three occasions (n = 3),
indicated above the heat maps as A, B, and C. miRNA, microRNA.
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miRNA proﬁle must precede regulation of mRNAs. There
were changes (P , 0.1, an acceptable threshold for explor-
atory data) in the proﬁle over time for 38 and 33 mature
miRNAs following C. albicans or S. aureus infection, respec-
tively, and 15 for PBS injection (Figure S3 and Table S5). Of
note, 13 of those modulated by S. aureus infection were also
affected by systemic C. albicans (Table S5), supporting the
notion their expression may indeed be regulated by Toll sig-
naling. However, when PBS and pathogen were compared at
the particular time points (Figure 4), from the 13 mature
forms, only miR-275-5p and miR-307a-3p (time 0), and
miR-305-5p/miR-306-5p/miR-307a-3p (1 hr) signiﬁcantly
separated (Table S5), and this was mostly due to there being
lower levels in response to C. albicans infection. Among the
miRNA proﬁles that changed over time were some required
to control the response to systemic C. albicans infection (Figure
6, and here we includemiR-137): C. albicans (miR-34-5p/miR-
137-3p/miR-313-5p); S. aureus (miR-34-5p/miR-277-5p/miR-
310-3p andmiR-310-5p/miR-311-3p); and PBS (miR-277-5p).
However, again, these differences did not come through
strongly at the particular time points; in fact, onlymature form
miR-137-3p was shown to separate, being higher at two time
points following C. albicans infection. In addition, miR-312-3p
was at a higher level (60 hr) and miR-34-3p at a lower level
(18 hr) in response to C. albicans and S. aureus infection. The
signal intensity values for miR-34 have been plotted as an exam-
ple of what the data generally looks like (Figure S4). This high-
lights three observations: (1) miRNAs whose proﬁles change
signiﬁcantly across time for a particular factor tend to do so at
the later time points and (2) do not separate so much from the
PBS baseline (miR-34-5p); and (3) where a difference is found
between PBS and pathogen at a particular time point it tends to
result from small error between biological repeats (miR-34-3p).
Systemic C. albicans infection promotes degradation
of BCAAs
To assess potential functions of the miRNAs shown to con-
tribute in controlling the response to systemic infection, we
used DIANATOOLS mirPath v.3 to predict the pathways and
genes they are likely to regulate (Vlachos et al. 2015) (Table
S6). Three of the most striking predictions were for miR-972
in modulating Hippo signaling and endocytosis, and for miR-
277 in regulating catabolism of BCAAs (valine, leucine, and
isoleucine); these are important nutrient signals that affect
metabolism, for example, through activating the mammalian
target of rapamycin complex 1 or serving as substrates for the
tricarboxylic acid (TCA) cycle (Yoon 2016). Given that miR-
277 does indeed regulate BCAA catabolism in D. melanogaster
(Esslinger et al. 2013), we ﬁrst examined whether infection
can affect the process, and second whether this is modiﬁed in
the miR-277-34 mutant.
We injected w control ﬂies and those of the miR-277-34
mutant with PBS or C. albicans and quantiﬁed their BCAA
content after 24 hr. This decreased signiﬁcantly in control
ﬂies during the 24-hr infection period whether they were
injected with PBS or infected (Figure 5); we attribute the
former to changes in metabolism that are likely to occur as
a result of keeping ﬂies at 30 during the infection period or
alternatively, as a result of the injection per se. Nevertheless,
within control ﬂies the BCAA content was signiﬁcantly lower
following infection relative to PBS injection after 24 hr (Fig-
ure 5). In contrast, within the miR-277-34 mutant, BCAA
levels were indistinguishable at 24 hr (Figure 5), although
reduced compared to the levels at the point of injection (time
0, Figure 5). However, we note that miR-277-34mutant ﬂies
had a signiﬁcantly lower BCAA content relative to the w con-
trol at the point of time of injection (time 0, Figure 5). This
suggests that BCAA catabolism was elevated in the mutant in
the absence of infection, consistent with a previous study that
demonstrated that overexpression ofmiR-277 negatively im-
pacted on BCAA catabolism (Esslinger et al. 2013). There-
fore, we propose that BCAA catabolism is constitutively
active in the miR-277-34 mutant, and that resolvable differ-
ences relating to infection are consequently lost. However,
the data demonstrate that systemic infection stimulates the
catabolism of BCAAs.
Figure 5 Systemic C. albicans infection con-
tributes to lowering the total level of BCAAs.
The total level of BCAAs within the w back-
ground and miR-277-34 mutant were mea-
sured at 0–24 hr following injection of PBS or
C. albicans. (A) There is a decrease over time
when w ﬂies are injected with either PBS or C.
albicans (P , 0.01 in both cases), and this re-
solves to a signiﬁcant difference in levels at
24 hr, being more extensive following infection
(P , 0.01). (B) This is similar to that observed
with the w background (over time P , 0.05 in
both cases), except there is no difference in
BCAA levels come 24 hr (P . 0.2). Data pre-
sented as the mean of three independent
biological experiments (n = 3/95% C.I.s);
repeated-measure two-way ANOVA and Bonferroni
correction were applied to determine statistical
differences. BCAA, branch-chained amino acid;
95% CI, 95% Conﬁdence interval.
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Discussion
Inanimal tissues,miRNAs regulatemanyaspectsof innateand
adaptive immunity, functioning within a variety of network
motifs that provide robustness to biological processes through
buffering or setting thresholds for protein production or cell
signaling (Ebert and Sharp 2012; Chen et al. 2013; Mehta and
Baltimore 2016).Here,wehave usedD.melanogaster as amodel
system to explore the relationship between miRNAs and the re-
sponse to systemic infection at the whole-organism level.
The miRNA biogenesis pathway
We ﬁrst observed that RNAi knockdown of Exp5 or over-
expression of Ago-1, manipulations that alter the miRNA
proﬁle of human cell lines (Maudet et al. 2014; Hata and
Kashima 2016), led to immune deﬁciency phenotypes. Al-
though survival proﬁles were indistinguishable when either
component was manipulated speciﬁcally in fat body tissue,
differences were seen regarding their effect on the level of
Drs transcript; with Ago-1 overexpression, Drs was not in-
duced in response to infection—behaving equivalently to a
Toll pathway mutant—whereas Drs transcript level was com-
parable to the control with RNAi knockdown of Exp5. This
suggests that the mechanism through which they exert their
effect is different. One possibility is that Ago-1 impacts di-
rectly on a component of the Toll pathway, as has been de-
scribed for Dcr-2, a key factor in the biogenesis of small
interfering RNAs (Wang et al. 2015). These authors showed
that Dcr-2 binds directly to the mRNA of Toll and promotes
production of the receptor; consequently, Dcr-2 mutant ﬂies
aremore sensitive to infection and exhibit reduced stimulation
of Toll. The fact that knockdown of Exp5 causes enhanced
susceptibility to systemic C. albicans infection, without appear-
ing to affect the output of Toll signaling, suggests that other
factors are dysregulated that otherwise contribute to promot-
ing survival; this may be a consequence of broad changes to
the miRNA proﬁle leading to widespread dysfunction of host
physiology.
Immune phenotypes of miRNA mutants
Our assessment regarding the contribution of individual or
small clusters of miRNAs in regulating events during the
infection process revealed thatmiR-277 andmiR-34 are likely
to have opposing effects on Toll signaling (Figure 6). Com-
promising the function of miR-277within the immune tissues
led to signiﬁcant overproduction of the Toll-dependent tran-
scripts Drs and IM1 in response to systemic C. albicans in-
fection, and regarding the latter, this was also true for PBS
injection. Given that infection-induced production of the IM1
transcript is exclusively dependent on the Toll receptor li-
gand Spz (De Gregorio et al. 2001, 2002), and that the tran-
script does not contain binding sites for miR-277 in its 39-UTR
or ORF, it seemsmost likely that Toll signaling is overactive in
the absence of miR-277; this implies that the miRNA func-
tions to reduce signaling through the pathway. Thus, the
strong IM1 response following PBS injection when miR-277
function is compromised (or strong Drs response following
sterile injury of the miR-277-34 mutant) may result from an
inability to downregulate a known stimulation in the produc-
tion of AMP transcripts that occurs early, and at a low level, in
response to pricking alone (Lemaitre et al. 1997). This sug-
gests that miR-277 may set a threshold to prevent robust
stimulation of Toll signaling in response to low-level stimuli.
In this regard, it could participate in a mechanism similar to
that described for miR-146, which is proposed to regulate
signaling through Toll-like receptor (TLR)4 at subinﬂammatory
levels (Schulte et al. 2013). In contrast, production of IM1
transcript within the miR-277-34 mutant was comparable to
that of the control following PBS injection, and actually
compromised in response to infection, suggesting that miR-
34 functions downstream of miR-277 to promote signaling
through the Toll pathway. This would explain why the
miR-277-34 mutant is susceptible to infection and does not
efﬁciently control pathogen number compared to a control
strain. An explanation as to why the level of the Drs transcript
is overproduced in this mutant following PBS injection or
infection may be direct targeting of the transcript, since it
has a putative binding site for miR-277. Therefore, in the
absence of miR-34, signaling through the Toll pathway
would be compromised but the Drs transcript would accumu-
late due to concomitant loss of miR-277-dependent degrada-
tion. An alternative explanation is that other dysregulated
pathways converge on the Toll pathway to induce Drs expres-
sion. For example, in Drosophila S2* cell culture, stimulating
the Ecdysone receptor in the presence of diaminopimelic
acid-type peptidoglycan induces production of Drs mRNA,
and this requires the transcription factor Br-C (Rus et al.
2013). Relevant here is the recent observation that overexpres-
sion of miR-34 leads to reduced abundance of the Br-C protein
(Xiong et al. 2016). Therefore, it may be that the level of Br-C is
elevated in the miR-277-34 mutant, and that this is somehow
provoked to induce the Drs transcript in response to pricking
and/or infection.
One reason why miR-277 and miR-34 would exert an
opposing inﬂuence on Toll signaling may be that they have
coevolved to regulate the response to infection, sincemiR-277
originates from miR-34 (Marco et al. 2013). This is also true
for miR-317, the mutant of which responds in a manner
equivalent to that of the miR-277-34 mutant regarding in-
fection. The elevated level of the Drs transcript observed
within themiR-317mutant in response to systemic C. albicans
is consistent with data showing that overexpression of miR-
317 leads to reduced production of the transcript following
Micrococcus luteus inoculation, and with miR-317 being
strongly predicted to target Pellino, a negative regulator of
the Toll pathway (Ji et al. 2014; Li et al. 2017b). ThatmiRNAs
do indeed regulate signaling through the Toll pathway has
been demonstrated for miR-958 (also identiﬁed in our micro-
array analysis), which when overexpressed in ﬂies leads to a
reduction in the levels of Toll and Dif protein and delays the
immune response (Li et al. 2017a). Only within the miR-193
mutant did the Drs transcript continue to increase across the
miRNAs in Drosophila Immunity 173
course of infection to a level higher than that of the control,
and this was associated with enhanced survival and lack of
pathogen growth, traits indicative of increased resistance.
Given its impact on suppressing the level of theDrs transcript,
it may be that miR-193 acts as a broad limiter after an in-
ﬂammatory response in a manner analogous to miR-155 and
signaling through TLR4 (Schulte et al. 2013). The miR-972-
973-974mutant has a complex phenotype, in that (following
both PBS injection and infection) it exhibits enhanced sur-
vival, pathogen number, and a level of Drs above that of the
control across the course of infection, and even at the point of
injection. It may be that members of this cluster regulate Toll
homeostasis and coordinate its response to infection. Involve-
ment in Toll homeostasis is akin to the role of mir-8, which
has been shown to suppress Toll signaling in adult fat body
tissue under steady-state conditions, potentially by blocking
the production of Toll (Choi and Hyun 2012; Lee and Hyun
2014). Regarding response to infection, miR-972 is predicted
to target 18 genes from theHippo signaling pathway, which is
involved in regulating the level of cactus mRNA and promot-
ing Drs production and survival in response to S. aureus in-
fection (Liu et al. 2016).
On a ﬁnal note, all the susceptible mutants exhibited an
increase in pathogen number despite an elevated level of Drs
transcript (exceptmiR-276b regarding Drs, which was equiv-
alent to the control). For themiR-277-34mutant, this may be
explained by a confounding interaction between miR-277
and miR-34, but for miR-317 and miR-276b only a single
miRNA is deleted. One aspect to consider when interpreting
miRNA data is that changes to even a single miRNA can affect
the levels of thousands of proteins, often in a complementary
manner (Selbach et al. 2008). This phenomenon explains
how a single miRNA can affect a plethora of biological func-
tions. For example, mir-8 has been shown to modulate the
activity of the EGFR, Notch, and Toll pathways, act as a link
between ecdysone and body growth, and affect motor neuron
innervations of muscle (Carthew et al. 2017). Therefore, the
disassociation between pathogen number and Toll signaling
may be a consequence of a global dysfunction, where path-
ways that work in combination with Toll to protect the host
Figure 6 Summary of phenotypes for selected miRNA mutant backgrounds. The table presents a summary for each miRNA mutant regarding changes
to pathogen number (CFUs) and level of Drs transcript over time (see Figure 2, B and C). Direction of arrows in the CFUs column and both Drs columns
(PBS and C. albicans) indicate how the measured variable changes over time for the particular miRNA background; a dash indicates there was not a
signiﬁcant change. The arrow/dash color represents whether the change is signiﬁcantly greater (orange) than that of the given w or yw control (gray) or
signiﬁcantly below (light orange) that of the given control; if the variable does not separate signiﬁcantly from the given control the arrow/dash is given as
gray. For details regarding P-values see Table S2. CFU, colony forming unit; miRNA, microRNA; n/a, not applicable.
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from systemic infection are disrupted. Alternatively, other
pathways that work independently of Toll to maintain gen-
eral homeostasis/health may be affected.
We show, within the susceptible miR-277-34mutant, that
the total amount of BCAAs is reduced compared to the con-
trol, consistent with previous ﬁndings implicatingmiR-277 as
a key factor in controlling the catabolism of BCAAs (Esslinger
et al. 2013). After 24 hr following PBS injection or infection,
the amount of BCAAs was further reduced to a nominal level,
thereby precluding conclusions regarding the latter. A possible
explanation for this is that the shift in temperature—from
25 to 30—accelerates metabolism, thereby driving the catab-
olism of BCAAs, given that its breakdown products are sub-
strates for the TCA cycle (2016). In control ﬂies, systemic
C. albicans infection contributes to acceleration of the break-
down of BCAAs. Therefore, it is possible that signaling
through Toll regulates BCAA metabolism by exerting an in-
hibitory effect on miR-277, thereby stimulating metabolism
to provide energy to ﬁght the infection; we note that miR-
277-5p continually declines following S. aureus inoculation,
which would theoretically release the repression on BCAA
catabolism during infection. Alternatively, it may be that
releasing a brake on metabolism, through the removal of
miR-277, impacts positively on the outcome of Toll signal-
ing; it has been seen in both mammals and Drosophila that
alterations to metabolism can modulate immune signaling,
with the two processes being antagonistic. A simple test for
the latter would be to reduce energy production through
manipulating the TCA cycle in a miR-277 mutant, which,
if the model is correct, should decrease the output of Toll
signaling. Consistent with the connection between BCAAs
and immune function, evidence shows that when they are
lacking in the human diet, many aspects of immunity are
impaired and susceptibility to pathogens is enhanced
(Zhang et al. 2017).
Genomic approaches to decipher miRNA involvement in
systemic infection
In an attempt to identify miRNAs responsive to systemic
infection, we performed a time course experiment on ﬂies
infected with different pathogens or injected with PBS, quan-
tifying the level of miRNAs from whole-body extracts via
microarray analysis. Approximately 90% of fold changes for
infected over PBS were .0.5 and ,2, including for the sta-
tistically separated (P , 0.1) miRNAs. Although it is not un-
usual to see signiﬁcant changes of this magnitude, for
example, in cultured cells following infection with different
pathogens (Jin et al. 2014; Siddle et al. 2015), changes
greater in magnitude are not uncommon. For example, the
NF-ĸB-dependent expression of miR-155 (Ceppi et al. 2009),
which participates in an incoherent feedforward loop to reg-
ulate TLR signaling in hematopoietic cells, increased .20-
fold in response to a variety of immune stimuli (Ryu et al.
2006; O’Connell et al. 2007; Siddle et al. 2015). More perti-
nent, a small-RNA-sequencing study identiﬁed 12 mature
miRNA forms that were differentially expressed [greater
than twofold (log2)] following systemic M. luteus infection
in D. melanogaster; overall, 32 miRNAs were shown to be
downregulated and 61 upregulated, with the vast majority
of changes occurring 24 hr following infection (Li et al.
2017b). Notably, miR-34-3p/miR-277-3p/miR-311-3p/miR-
973-3p were included in the upregulated miRNAs, and miR-
34-5p/miR-276b-5p/miR-277-5p/313-5p/miR-317-3p and
miR-317-5p were included in those that were downregu-
lated. Regarding our miRNA microarray data, in general,
we did not ﬁnd consistency between miRNAs whose proﬁles
changed over time for a particular pathogen and those dif-
ferentially expressed relative to PBS. Therefore, we speculate
that a critical aspect in the response to infection for some
miRNAs is to maintain a relatively constant slope of produc-
tion over time. This seems reasonable considering the time
series heat maps, where themajority of statistically separated
miRNA proﬁles switch from upregulated to downregulated
(based on Z-score, thus changes given relative to the associ-
ated data set), or vice versa, at the later time points. Another
consideration is that PBS injection may have an inconsistent
effect on miRNA proﬁles; as such, their production may be
similar to that for infected ﬂies, but they will not be deﬁned
over time. It would be useful to know how miRNA proﬁles
change in untreated ﬂies. An interesting aside is that the
switching at later time points (or general direction of the
slope over time) may be a priming mechanism for a rapid
response to further infection, once production of immune-
stimulated transcripts has returned to basal level. For exam-
ple, miR-958-5p and miR-34-5p tend to slope downward and
upward, respectively, over the course of infection. Regarding
the action of miR-958, this would in theory lead to increased
production of Toll and Dif protein, whereas for miR-34 this
would increase signaling through the Toll pathway.
ThemajorityofmaturemiRNAforms (297of425)werenot
detected above background across the time course for PBS
injected or infected ﬂies, including both arms for members of
the miR-972-973-974 and miR-959-964 clusters. This is no-
table given that deleting the former, or four members of the
latter (Vodala et al. 2012), alters the response to systemic
infection. More speciﬁcally, members of the miR-959-964
cluster were shown to cycle – albeit at a relatively low abun-
dance – via circadian transcriptional control, where ex-
pression was most prominent in the adult head fat body.
Signiﬁcantly, when this cluster was partially deleted, the time
during the light:dark cycle at which ﬂies were most suscep-
tible to gram-negative infection was shifted (Vodala et al.
2012). That we did not observe enhanced susceptibility of
this mutant to C. albicans may be partly explained therefore,
by the timing of our infections; however, this phenomenon is
likely to be a rare event, since most miRNAs do not exhibit
circadian oscillations (Vodala et al. 2012). These observa-
tions bring to attention the dynamism and speciﬁcity of
miRNA expression, and that having mature miRNAs at low
abundance does not preclude important functional output.
Considering this, using quantifying techniques with greater
sensitivity (for example Small-RNA-Sequencing) and analyzing
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particular tissues or cells from infected ﬂies, is likely to be more
revealing. More so, if immune deﬁcient ﬂies are analyzed in
parallel. Reporter constructs with rapid-turnover ﬂuorescent
proteins would also be a useful tool in the study of miRNAs.
Therefore, in relation to immunity, we have provided a ge-
nome-wide map of potential NF-kB-binding sites that reside
in close proximity to miRNA genes. However, we should be
cautiouswhen relating strength of those potential sites and role
in immunity as there was no such correlation in our ﬁndings.
Conclusions
Wehave identiﬁed sixmiRNAallelicmutant backgrounds that
affect survival in response to systemic infection, the ability to
control pathogen number, and production of Toll pathway-
dependent transcripts. Furthermore, we reveal infection
contributes to promoting BCAA catabolism, and through
the susceptible miR-277-34 mutant, identify a potential
connection between BCAA catabolism and Toll signaling.
Future studies carefully detailing the expression, tissue-
speciﬁc requirement, and functional interactions between
these miRNAs and their targets, will undoubtedly reveal
new insight into the mechanisms required to cope with
systemic infection.
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